Full Breakdown
Halsey vs. Anthony Fantano: A Clash Over “The Great Impersonator” and Women’s Health Narratives
6/23/2026, 12:39:55 AM
The Triggering Review and Halsey’s Counter-Response
On Oct 29 2024, music-critic Anthony Fantano posted a nine-minute YouTube review of Halsey’s fifth studio album, *The Great Impersonator*. He assigned a “light-to-decent 1” out of 10 and labeled the record “the worst case of main-character syndrome I’ve heard on any pop album in 2024.” In June 2026, Halsey replied on X, emphasizing that the dispute was not about the low score but about Fantano’s framing of her medical suffering as self-obsession.
Health Context and Album Themes
Halsey has publicly disclosed a diagnosis of systemic lupus erythematosus (SLE) and a rare T-cell lymphoproliferative disorder, for which she began chemotherapy in 2022. In June 2024 she posted treatment footage, tagging the Lupus Research Alliance and the Leukemia & Lymphoma Society, linking the album’s lyrical content to her two-year health battle. *The Great Impersonator* is presented as a high-concept work exploring identity, mortality, and the experience of “performing yourself while feeling physically unrecognisable.”
Key Players and Their Public Positions
- Halsey – Grammy-nominated singer, using the dispute to highlight broader fears women face when describing chronic pain.
- Anthony Fantano – YouTube host of “The Needle Drop,” asserting his critique focused on songwriting and concept, not on Halsey’s illness.
- Lupus Research Alliance & The Leukemia & Lymphoma Society – Organizations thanked by Halsey for raising disease awareness.
Numbers Behind the Debate
- Fantano’s rating: 1/10 (light-to-decent 1).
- NME: five-star review; Pitchfork: 4.8/10; Rolling Stone: 4/5 stars.
- Billboard 200 debut: No. 2.
- First-week U.S. sales: ~100,000 copies (as cited by Halsey).
- Album length: 18 tracks, 2024 release.
Broader Significance for Music Criticism and Women’s Pain
The exchange has become a flashpoint for discussions about how critics address art rooted in personal health narratives, and whether women’s disclosures of chronic illness are routinely dismissed as “attention-seeking.” Observers note the tension between artistic merit and empathy for lived experience, suggesting the debate may reshape expectations for criticism of confessional pop.
Official Statements & Responses
Halsey’s X posts framed Fantano’s language as validating a cultural fear among women with serious illnesses. Fantano, speaking to Variety, emphasized that his review was based on “weak songwriting” and “poor execution of inspirations,” denying any gender-based motive and reiterating his support for women artists he admires.
Criticism & Opposition
Fans and commentators split: some defend Fantano’s right to critique regardless of personal context, while others argue that dismissing a work centered on medical trauma reinforces misogynistic patterns of disbelief.
Conflicting Reports & Gaps
Sources differ on the extent of the album’s commercial performance: Halsey cites 100,000 first-week sales, whereas other outlets provide only chart position data. No direct response from Fantano’s team beyond the Variety interview is documented.
Verbatim Quotes
- “But at least I had the excuse of going through chemo.” — Halsey, X (June 21 2026)
- “Being a woman dealing with serious health issues often means being afraid of telling the truth about the pain you’re in because you’re afraid of not being believed or seeming attention seeking. He validated that fear to thousands of women.” — Halsey, X (June 22 2026)
- “I’m not the devil himself for not enjoying this album.” — Anthony Fantano, Variety interview (2026)
- “I have been the most relevant and impactful music critic of my — and any — generation for over 10 years now.” — Anthony Fantano, Variety interview (2026)
What’s Next
Both parties remain active on social media, and the conversation is expected to re-emerge as Halsey promotes upcoming tour dates and as Fantano continues his interview circuit. Media outlets indicate the dispute will likely be cited in future debates over the ethics of critiquing art that foregrounds personal health narratives.
